AstraZeneca resumes US COVID-19 vaccine trial

Oct 24, 2020

London [UK], October 24 : The clinical trials for the AstraZeneca Oxford coronavirus vaccine -- AZD1222 -- have resumed in the United States after...

AZD1222 vaccine met primary efficacy endpoint in preventing COVID-19, efficacy jumps to 90 pc

Nov 23, 2020

New Delhi [India], November 23 : With an efficacy of around 90 per cent positive results from an interim analysis of clinical trials of...